Optimi Health Completes First Production of Novel MDMA Drug Candidate OPTI-MHCL
The Company is producing OPTI-MHCL in-house under its Health Canada issued Dealers Licence using Optimi's scalable, proprietary production method.
Source: medindia.net
Page 30 - Special Access Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Special Access Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Special Access Program Today - Breaking & Trending Today
Psychedelic therapies emerging as mental health treatment in Sask.
Dr. Monika Hooper, a psychiatrist at the Linden Medical Centre in Saskatoon, says ketamine assisted psychotherapy help treat 70 per cent of patients who are suffering from PTSD or treatment resistant depression.
Source: cbc.ca
Numinus Wellness Inc receives clinical trial application approval from Health Canada for experiential psychedelic-assisted therapy training using Psilocybe cubensis tea
Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) announced that it has received approval from Health Canada for its experiential training study that will test...
Source: proactiveinvestors.com
Numinus Receives Clinical Trial Application Approval from Health Canada for Experiential Psychedelic-Assisted Therapy Training using Psilocybe Cubensis Tea
/PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and...
Source: prnewswire.com
Biden and Trump Both Mishandled Classified Documents – But the Cases Appear Different
As soon as the documents were unearthed, the Biden team cooperated with the authorities, proactively inviting a search of Biden properties. The contrast with Trump is stark.
Source: thewire.in